Orchestra Biomed Holdings Inc
NASDAQ:OBIO
Income Statement
Earnings Waterfall
Orchestra Biomed Holdings Inc
Income Statement
Orchestra Biomed Holdings Inc
| Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||
| Revenue |
(1)
N/A
|
(1)
-58%
|
0
N/A
|
(0)
N/A
|
4
N/A
|
4
+8%
|
4
+14%
|
4
-17%
|
3
-23%
|
2
-19%
|
2
-6%
|
3
+27%
|
3
0%
|
3
+9%
|
3
+2%
|
3
-4%
|
|
| Gross Profit | |||||||||||||||||
| Cost of Revenue |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Gross Profit |
(1)
N/A
|
(1)
-47%
|
(0)
+99%
|
(0)
-1 800%
|
3
N/A
|
4
+11%
|
4
+13%
|
3
-18%
|
3
-25%
|
2
-21%
|
2
-6%
|
2
+28%
|
2
-1%
|
3
+10%
|
3
+2%
|
3
-4%
|
|
| Operating Income | |||||||||||||||||
| Operating Expenses |
(21)
|
(22)
|
(25)
|
(31)
|
(36)
|
(43)
|
(49)
|
(52)
|
(54)
|
(58)
|
(61)
|
(64)
|
(67)
|
(71)
|
(74)
|
(78)
|
|
| Selling, General & Administrative |
(8)
|
(8)
|
(9)
|
(13)
|
(14)
|
(16)
|
(18)
|
(19)
|
(20)
|
(22)
|
(23)
|
(22)
|
(24)
|
(24)
|
(24)
|
(26)
|
|
| Research & Development |
(13)
|
(13)
|
(16)
|
(18)
|
(22)
|
(27)
|
(30)
|
(33)
|
(34)
|
(35)
|
(37)
|
(40)
|
(43)
|
(47)
|
(50)
|
(52)
|
|
| Operating Income |
(22)
N/A
|
(23)
-6%
|
(25)
-9%
|
(31)
-23%
|
(33)
-6%
|
(40)
-22%
|
(44)
-12%
|
(49)
-10%
|
(52)
-5%
|
(56)
-8%
|
(59)
-7%
|
(61)
-3%
|
(64)
-5%
|
(69)
-7%
|
(71)
-4%
|
(75)
-6%
|
|
| Pre-Tax Income | |||||||||||||||||
| Interest Income Expense |
(1)
|
(2)
|
(1)
|
(1)
|
(0)
|
1
|
1
|
3
|
4
|
4
|
4
|
4
|
3
|
2
|
2
|
0
|
|
| Non-Reccuring Items |
0
|
0
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(23)
N/A
|
(25)
-10%
|
(27)
-7%
|
(32)
-19%
|
(34)
-5%
|
(39)
-16%
|
(43)
-11%
|
(46)
-7%
|
(49)
-7%
|
(52)
-5%
|
(56)
-8%
|
(58)
-4%
|
(61)
-6%
|
(66)
-9%
|
(70)
-5%
|
(75)
-8%
|
|
| Net Income | |||||||||||||||||
| Income from Continuing Operations |
(23)
|
(25)
|
(27)
|
(32)
|
(34)
|
(39)
|
(43)
|
(46)
|
(49)
|
(52)
|
(56)
|
(58)
|
(61)
|
(66)
|
(70)
|
(75)
|
|
| Net Income (Common) |
(23)
N/A
|
(25)
-10%
|
(27)
-7%
|
(32)
-19%
|
(36)
-12%
|
(39)
-9%
|
(43)
-11%
|
(46)
-7%
|
(49)
-7%
|
(52)
-5%
|
(56)
-8%
|
(58)
-4%
|
(61)
-6%
|
(66)
-9%
|
(70)
-5%
|
(75)
-8%
|
|
| EPS (Diluted) |
-0.73
N/A
|
-0.79
-8%
|
-0.85
-8%
|
-1.01
-19%
|
-1.13
-12%
|
-1.4
-24%
|
-1.24
+11%
|
-1.3
-5%
|
-1.48
-14%
|
-1.44
+3%
|
-1.57
-9%
|
-1.53
+3%
|
-1.66
-8%
|
-1.73
-4%
|
-1.83
-6%
|
-1.43
+22%
|
|